Dental Biomaterial Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Material (Metallic Biomaterials (Titanium, Stainless Steel, Other), Ceramic Biomaterials, Polymeric Biomaterials, Others), By Application (Implantology, Prosthetic, Orthodontic, Others), By End User (Hospitals, Clinics, Academies and Research Laboratories), And By Geography - Forecasts From 2022 To 2027

The global dental biomaterial market is expected to grow at a CAGR of 9.21% over the forecast period to reach a total market size of US$18.801 billion by 2030, increasing from US$12.102 billion in 2025.

Dental biomaterials include all types of natural and biocompatible synthetic materials used to restore damaged and decayed teeth. The increasing prevalence of dental disorders coupled with the rising penetration of dental implants is expected to drive the growth of the market during the forecast period. However, stringent regulation and the clinical process are anticipated to restrain the growth of the market in the coming years.

Dental implants and prosthetics are mostly used either for filling oral cavities or replacing them with a concrete solution and according to the World Health Organization, more than 3 billion people in the world are affected by oral health problems. A dental implant is a kind of oral prosthetic in which the gum is opened and in the cavity is positioned a prosthetic crown. Planning the position and number of implants is key to the long-term health of the prosthetic since biomechanical forces created during chewing can be significant.

What are the drivers of the dental biomaterial market?

• The growing geriatric population is driving the market.

The geriatric population is growing at a high rate, which is a major driver for the dental biomaterial market. Aging causes several factors such as reduced salivary flow, loss of bone density, and prolonged wear and tear, which make older people more susceptible to dental problems like tooth decay, gum diseases, and tooth loss. This demographic trend increases the demand for dental biomaterials, including implants, crowns, bridges, and dentures, which are necessary for restorative and cosmetic dental procedures. This would be further boosted by the need of the growing population for improved dental biomaterials in terms of durability, biocompatibility, and aesthetics.

The increase in living standards, due to the rising disposable income of the individuals has increased life expectancy and has led to a rise in the geriatric population in different regions of the world. As per the Population Reference Bureau, the number of Americans above 65 is projected to grow significantly from 58 billion in 2022 to 82.5 billion by 2050, which is a 47% increase. Additionally, the proportion of the whole population belonging to people aged 65 or older will grow from 17% to 23% in the future years.

• Increasing prevalence of oral health problems.

The growth in the dental biomaterial market is primarily due to the growing incidence of oral health issues. These include dental caries, periodontal diseases, tooth loss, and edentulism, among others, that have been exacerbated by poor oral hygiene, dietary habits high in sugar, tobacco use, and an aging population. These issues often require restorative or prosthetic treatments, such as fillings, crowns, bridges, dentures, and implants, all of which rely on advanced dental biomaterials. As the number of people requiring these treatments grows, so does the demand for high-quality biomaterials that ensure successful outcomes.

The state of teeth, gums, and overall oral-facial system, which enables people to chew, talk, and smile is referred to as oral health. Oral cancer, gum disease, and cavities are some of the most prevalent conditions that affect our oral health. By the time they are 34 years old, over 80% of people will have had at least one cavity and over 40% of adults report having had dental discomfort in the previous year. The annual expense of dental treatment in the country is about $124 billion. Dental crises necessitating emergency care cost the economy more than $45 billion annually in lost productivity and more than 34 million school hours annually.

• Advancements in Dental Technologies.

Advancements in dental technologies are revolutionizing the dental biomaterial market by enhancing precision, durability, and aesthetics. The breakthrough is the development of advanced materials such as zirconia, hydroxyapatite, and bioactive glass, which offer superior biocompatibility and integration with natural tissues. Risks of rejection are reduced, and the longevity of dental implants, crowns, and bridges is improved. Nanostructured biomaterials that mimic natural tooth and bone properties have made it possible due to nanotechnology, which enhances faster healing with better functionality. Smart materials, in addition, could respond to environmental changes that include pH and temperature, offering innovative applications that include controlled drug release and remineralization.

Digital dentistry has significantly simplified dental restoration procedures, making them faster and more precise. CAD/CAM systems and 3D printing allow even the most accurate designs and fabrications of dental prosthetics, ensuring a proper fit with successful patient outcomes. Intraoral scanners eliminate the use of traditional molds in dental practices, reducing patient discomfort and errors while improving the comprehensive practice. This thereby enables the production of precise-fit dental solutions based on the specific needs of the individual while reducing the time and cost of treatment. Improved adhesives and bonding agents have increased durability and reliability among these biomaterials, with greater attraction toward both patients and practitioners.

The dental biomaterial market is segmented into five regions worldwide:

The global dental biomaterial market is segmented into five regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The North American region is expected to hold a significant share of the market owing to the presence of major players coupled with the growing geriatric population. In Europe, favorable government initiatives on oral healthcare, combined with increased adoption of dental biomaterials for the fabrication of implants and other dental products, are expected to drive the regional market in the coming years.  Besides, rising disposable income and the growing number of dental hospitals, the market for dental biomaterials is anticipated to witness exponential growth in the Asia Pacific region.

On the other hand, driving factors of the Asia Pacific dental biomaterial market remain demographic changes, increasing oral health conditions, and improved healthcare solutions. The aging population is at the forefront, particularly in Japan, China, and South Korea; because older individuals are more susceptible to tooth loss and gum disease, demand for implants and restorative solutions increases. Apart from this, increased oral health problem incidence because of improper hygiene, unhealthy dietary habits, and tobacco has added to the need for advanced biomaterial treatments. There is a surge in oral health awareness, plus a growing infrastructure in healthcare systems, and affordability in dental treatment that is bolstering the growth of the market. Technological advancements such as 3D printing and biocompatible materials are also being rapidly adopted in the region, catering to both functional and aesthetic dental needs.

Dental biomaterial Market Key Developments:

• In July 2024, Mitsui Chemicals, Inc. reported that its subsidiary SUN MEDICAL CO., LTD. has commenced sales of the i-TFC™ Luminous II dental material range.
• In February 2024, SprintRay Inc., a digital dentistry and 3D printing solutions pioneer, announced the launch of a suite of cutting-edge products from the company's Biomaterial Innovation Lab. The innovations include the NanoCure post-curing device, NightGuard Flex 2, NightGuard Firm 2, Apex Base, and Apex Teeth resins, all of which mark a giant leap in dental 3D printing technology.
• In February 2024, ZimVie Inc., a global life sciences leader in the dental and spine markets, announced the launch of the TSX Implant in Japan.
• In February 2024, 3D Systems introduced a first-to-market solution for jetted, monolithic (one-piece) dentures that utilizes multiple materials to deliver a durable, long-wear, aesthetically beautiful prosthetic to the patient.

The dental biomaterial market is segmented and analyzed as follows:

• By Material
  • Metallic Biomaterials
    • Titanium
    • Stainless Steel
    • Other
  • Ceramic Biomaterials
  • Polymeric Biomaterials
  • Others
• By Application
  • Implantology
  • Prosthodontics
  • Orthodontics
  • Others
• By End-user
  • Hospitals
  • Clinics
  • Academies and Research Laboratories
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Supplier

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. DENTAL BIOMATERIAL MARKET BY MATERIAL

5.1. Introduction 

5.2. Metallic Biomaterials

5.2.1. Titanium

5.2.2. Stainless Steel

5.2.3. Other

5.3. Ceramic Biomaterials

5.4. Polymeric Biomaterials

5.5. Others

6. DENTAL BIOMATERIAL MARKET BY APPLICATION

6.1. Introduction

6.2. Implantology

6.3. Prosthodontics

6.4. Orthodontics

6.5. Others

7. DENTAL BIOMATERIAL MARKET BY END-USER

7.1. Introduction

7.2. Hospitals

7.3. Clinics

7.4. Academies and Research Laboratories

8. DENTAL BIOMATERIAL MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Straumann AG

10.2. Royal DSM

10.3. Geistlich Pharma AG

10.4. ZimVie Inc

10.5. 3M Company

10.6. Dentsply Sirona, Inc

10.7. Kuraray Co., Ltd

10.8. Mitsui Chemicals, Inc

10.9. DMP Dental Industry S.A

Straumann AG

Royal DSM

Geistlich Pharma AG

ZimVie Inc

3M Company

Dentsply Sirona, Inc

Kuraray Co., Ltd

Mitsui Chemicals, Inc

DMP Dental Industry S.A